The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $2.36

Today's change+0.20 +9.26%
Updated April 21 4:03 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $2.36

Today's change+0.20 +9.26%
Updated April 21 4:03 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc crosses above 20-day moving average

BioAmber Inc closed up sharply Friday, rallying (U.S.)$0.20 or 9.26% to (U.S.)$2.36 and crossing above its 20-day moving average. Over the last five days, shares have gained 1.72%, but are down 57.09% for the last year to date. Shares have underperformed the S&P 500 by 60.54% during the last year.

Key company metrics

  • Open(U.S.) $2.16
  • Previous close(U.S.) $2.16
  • High(U.S.) $2.52
  • Low(U.S.) $2.15
  • Bid / Ask-- / --
  • YTD % change-57.09%
  • Volume169,271
  • Average volume (10-day)171,569
  • Average volume (1-month)267,562
  • Average volume (3-month)247,814
  • 52-week range(U.S.) $2.00 to (U.S.) $6.50
  • Beta2.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.79
Updated April 21 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-342.95%

BioAmber Inc has a net profit margin of -342.95%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.07%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue1431
Total other revenue--------
Total revenue1431
Gross profit-1-1-1-2
Total cost of revenue2533
Total operating expense8101010
Selling / general / administrative3244
Research & development2222
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0--0--
Other operating expenses, total--------
Operating income-7-7-7-9
Interest income (expense), net non-operating-2-3-2-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-12-73-13
Income after tax-12-73-13
Income tax, total0000
Net income-10-65-11
Total adjustments to net income--------
Net income before extra. items-10-65-11
Minority interest2122
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-65-11
Inc. avail. to common incl. extra. items-10-65-11
Diluted net income-10-65-11
Dilution adjustment----0--
Diluted weighted average shares29293028
Diluted EPS excluding extraordinary itemsvalue per share-0.35-0.210.16-0.39
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.35-0.210.16-0.39